Helical CT Imaging Accurately Guides Radiation Therapy
|
By MedImaging International staff writers Posted on 21 Jan 2021 |

Image: The Accuray Radixact System with ClearRT (Photo courtesy of Accuray)
A cutting-edge imaging solution produces high quality computerized tomography (CT) scans to enhance the versatility and efficiency of radiation therapy (RT) procedures.
The Accuray (Sunnyvale, CA) ClearRT Imaging Solution is a helical kVCT system that provides fan-beam capabilities at both kV and MV wavelengths. The large transverse field of view and continuous scan length enable rapid acquisition and facilitate patient setup and registration, including for patients with metal implants, which is a contraindication for alternative magnetic resonance (MR) imaging. The system offers both excellent uniformity and low noise across the entire scanned image, with improved soft tissue visualization and spatial resolution.
The ClearRT imaging solution integrates seamlessly into the Accuray Radixact System, delivering imaging capabilities comparable to conventional linear accelerator systems that rely on cone-beam CT (CBCT) imaging. It leverages the same 5-step delivery workflow as the Radixact System. Additionally, ClearRT helical kVCT images will be available within the Accuray PreciseART automated dose trending tool for clinicians to evaluate if plan adaptation would be beneficial, enabling personalized patient care.
“ClearRT integrates with other Accuray-only applications on the Radixact System, making it possible for providers to offer a new level of precision and accuracy in the treatment of the simplest to the most complex pathologies,” said Suzanne Winter, senior vice president of R&D at Accuray. “Our continuing innovation on the Radixact System is designed to leverage its 360-degree, helical delivery platform to facilitate hypofractionated and ultra-hypofractionated treatments that support our customers' efforts to maintain the highest standard of care for their community.”
The Radixact System is an image guided, intensity modulated radiation therapy (IG-IMRT) system with a unique ultra-fast binary multi-leaf collimator (MLC) and a continuous 360 degree ring gantry with low-dose helical fan beam technology revolving at 10 RPM. Using the refined x-ray beamline and integrated imaging solution enables clinicians to deliver highly accurate dose distributions that conform precisely to the shape of the patient’s tumor and minimize RT dose to normal, healthy tissue.
The Accuray (Sunnyvale, CA) ClearRT Imaging Solution is a helical kVCT system that provides fan-beam capabilities at both kV and MV wavelengths. The large transverse field of view and continuous scan length enable rapid acquisition and facilitate patient setup and registration, including for patients with metal implants, which is a contraindication for alternative magnetic resonance (MR) imaging. The system offers both excellent uniformity and low noise across the entire scanned image, with improved soft tissue visualization and spatial resolution.
The ClearRT imaging solution integrates seamlessly into the Accuray Radixact System, delivering imaging capabilities comparable to conventional linear accelerator systems that rely on cone-beam CT (CBCT) imaging. It leverages the same 5-step delivery workflow as the Radixact System. Additionally, ClearRT helical kVCT images will be available within the Accuray PreciseART automated dose trending tool for clinicians to evaluate if plan adaptation would be beneficial, enabling personalized patient care.
“ClearRT integrates with other Accuray-only applications on the Radixact System, making it possible for providers to offer a new level of precision and accuracy in the treatment of the simplest to the most complex pathologies,” said Suzanne Winter, senior vice president of R&D at Accuray. “Our continuing innovation on the Radixact System is designed to leverage its 360-degree, helical delivery platform to facilitate hypofractionated and ultra-hypofractionated treatments that support our customers' efforts to maintain the highest standard of care for their community.”
The Radixact System is an image guided, intensity modulated radiation therapy (IG-IMRT) system with a unique ultra-fast binary multi-leaf collimator (MLC) and a continuous 360 degree ring gantry with low-dose helical fan beam technology revolving at 10 RPM. Using the refined x-ray beamline and integrated imaging solution enables clinicians to deliver highly accurate dose distributions that conform precisely to the shape of the patient’s tumor and minimize RT dose to normal, healthy tissue.
Latest Nuclear Medicine News
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
Channels
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read more
Hybrid AI System Improves Early Lung Cancer Detection on CT
Early lung cancer often presents as tiny nodules on computed tomography (CT) that are difficult to distinguish from normal tissue, leading to delayed diagnoses. Missed or late findings limit timely intervention... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







